Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant.

The carrier frequency of Asn291Ser polymorphism of the lipoprotein lipase (LPL) gene is 4;-6% in the Western population. Heterozygotes are prone to fasting hypertriglyceridemia and low high density lipoprotein (HDL) cholesterol concentrations especially when secondary factors are superimposed on the genetic defect. We studied the LPL Asn291Ser gene variant as a modulator of postprandial lipemia in heterozygote carriers. Ten normolipidemic carriers were compared to ten control subjects, who were selected to have similar age, sex, BMI, and apolipoprotein (apo)E-phenotype. The subjects were given a lipid-rich mixed meal and their insulin sensitivity was determined by euglycemic hyperinsulinemic clamp technique. The two groups had comparable fasting triglycerides and glucose utilization rate during insulin infusion, but fasting HDL cholesterol was lower in carriers (1.25 +/- 0.05 mmol/L) than in the control subjects (1. 53 +/- 0.06 mmol/L, P = 0.005). In the postprandial state the most pronounced differences were found in the very low density lipoprotein 1 (VLDL1) fraction, where the carriers displayed higher responses of apoB-48 area under the curve (AUC), apoB-100 AUC, triglyceride AUC, and retinyl ester AUC than the control subjects. The most marked differences in apoB-48 and apoB-100 concentrations were observed late in the postprandial period (9 and 12 h), demonstrating delayed clearance of triglyceride-rich particles of both hepatic and intestinal origin. Postprandially, the carriers exhibited enrichment of triglycerides in HDL fraction. Thus, in normolipidemic carriers the LPL Asn291Ser gene variant delays postprandial triglyceride, apoB-48, apoB-100, and retinyl ester metabolism in VLDL1 fraction and alters postprandial HDL composition compared to matched non-carriers.

[1]  Taskinen,et al.  Comparison of three fatty meals in healthy normolipidaemic men: high post‐prandial retinyl ester response to soybean oil , 1998, European journal of clinical investigation.

[2]  J. Hokanson,et al.  Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.

[3]  A. V. van Beek,et al.  Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity. , 1998, Journal of lipid research.

[4]  M. Taskinen,et al.  The Asn‐291→Ser and Ser‐477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia , 1997, European journal of clinical investigation.

[5]  A. Cooper Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.

[6]  J. Boer,et al.  Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. , 1997, Circulation.

[7]  M. Taskinen,et al.  Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  P. Schnohr,et al.  A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. , 1997, The Journal of clinical investigation.

[9]  M. Taskinen,et al.  Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM , 1997, Diabetologia.

[10]  M. Hayden,et al.  Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. , 1996, The New England journal of medicine.

[11]  M. Hayden,et al.  A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. , 1996, Journal of lipid research.

[12]  M. Taskinen,et al.  Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. , 1996, Journal of lipid research.

[13]  I. Goldberg Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.

[14]  D. Gaudet,et al.  Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Hayden,et al.  Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[16]  F. Karpe,et al.  Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. , 1995, Journal of lipid research.

[17]  G. Olivecrona,et al.  Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. , 1995, Journal of lipid research.

[18]  J. Björkegren,et al.  Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Taylor,et al.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Hamsten,et al.  Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. , 1994, Journal of lipid research.

[21]  J Ludbrook,et al.  Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.

[22]  R. Havel,et al.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Paulweber,et al.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. , 1993, The Journal of clinical investigation.

[24]  S. Humphries,et al.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.

[25]  J. K. Dunn,et al.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  N. Le,et al.  Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. , 1992, Journal of lipid research.

[27]  K. Polonsky,et al.  Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. , 1992, The Journal of clinical endocrinology and metabolism.

[28]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Kaplan,et al.  Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. , 1991, The Journal of clinical investigation.

[30]  A. Takagi,et al.  A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. , 1990, Journal of lipid research.

[31]  D G Altman,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[32]  A. Consoli,et al.  Mechanism for Underestimation of Isotopically Determined Glucose Disposal , 1989, Diabetes.

[33]  J. Ordovás,et al.  Postprandial plasma lipoprotein changes in human subjects of different ages. , 1988, Journal of lipid research.

[34]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[35]  P. de Knijff,et al.  A rapid micromethod for apolipoprotein E phenotyping directly in serum. , 1987, Journal of lipid research.

[36]  A. Tall,et al.  Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. , 1986, The Journal of clinical investigation.

[37]  C. Fielding,et al.  Effects of postprandial lipemia on plasma cholesterol metabolism. , 1985, The Journal of clinical investigation.

[38]  R. Havel,et al.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[40]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[41]  D. Porte,et al.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. , 1973, The Journal of clinical investigation.

[42]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[43]  P. Julien,et al.  Molecular pathobiology of the human lipoprotein lipase gene. , 1996, Pharmacology & therapeutics.

[44]  M. Taskinen,et al.  Development and Evaluation of an ELISA Method for the Determination of Lipoprotein Lipase Mass Concentration — Comparison with a Commercial, One-Step Enzyme Immunoassay , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[45]  M. Hayden,et al.  A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis , 1995, Nature Genetics.

[46]  A. Hamsten,et al.  Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. , 1995, Journal of lipid research.

[47]  D. Arveiler,et al.  Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde. , 1995, Journal of lipid research.

[48]  A Sajantila,et al.  Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. , 1993, American journal of human genetics.

[49]  G. Watts,et al.  Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia. , 1993, Journal of lipid research.

[50]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[51]  J. Brunzell Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome , 1989 .

[52]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[53]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.